Dermatologic Manifestations of Menkes Kinky Hair Disease Treatment & Management
- Author: Suguru Imaeda, MD; Chief Editor: William D James, MD more...
Medical care is mainly supportive for Menkes kinky hair syndrome patients.
The administration of parenteral copper is ineffective at influencing the clinical course and fatal outcome. However, early parenteral administration has been demonstrated to prevent some neurological disturbances. Some patients who receive copper-histidinate supplementation have serum copper and ceruloplasmin levels in the reference range.[21, 22] Despite these levels, their clinical features are unaltered.
Intracerebroventricular copper histidine injection in a rat model of Menkes disease restored the brain copper concentration, suggesting the possibility of this method as a novel treatment approach in Menkes disease infants with severe mutations.
The use of antiseizure medications may be indicated.
One clinical trial measured plasma dopamine, norepinephrine, dihydroxyphenylacetic acid, and dihydroxyphenylglycol levels in 81 infants at risk. In 12 newborns who met the eligibility criteria, copper-replacement therapy was begun within 22 days after birth. Survival and neurodevelopment was tracked longitudinally for 1.5-8 years; survival at a median follow-up of 4.6 years was 92%, compared with 13% at a median follow-up of 1.8 years for a historical control group of 15 late-diagnosis and late-treatment patients. Two of the 12 patients had normal neurodevelopment and brain myelination.
Patients with Menkes kinky hair syndrome frequently have multiple issues that complicate anesthetic management.[25, 26] Physical characteristics (eg, small chin, prominent upper incisors) alter airway anatomy, and marked dental fragility make airway management potentially difficult. Alternatives to traditional direct laryngoscopy may be more suitable for these patients. The propensity for tooth fracture during laryngoscopic manipulation may be related to the defective collagen and connective-tissue formation that are characteristic of Menkes kinky hair syndrome.
Consult a neurologist for seizure management.
Consult a geneticist for counseling and prenatal testing. Prenatal diagnosis by means of DNA mutational analysis (preferred method) may be performed. Copper-64 incorporation by cultured chorionic villus cells or amniocytes may be observed.
Carrier status can be determined by observing copper-64 uptake in cultured fibroblasts or by means of DNA mutational analysis, which is the preferred method. Denaturing high-performance liquid chromatography has been used effectively for mutation screening in patients with Menkes disease.
Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics. 1962 May. 29:764-79. [Medline].
Danks DM, Campbell PE, Stevens BJ, Mayne V, Cartwright E. Menkes's kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics. 1972 Aug. 50(2):188-201. [Medline].
Danks DM, Campbell PE, Walker-Smith J, et al. Menkes' kinky-hair syndrome. Lancet. 1972 May 20. 1(7760):1100-2. [Medline].
Price DJ, Ravindranath T, Kaler SG. Internal jugular phlebectasia in Menkes disease. Int J Pediatr Otorhinolaryngol. 2007 Jul. 71(7):1145-8. [Medline].
Oshio T, Hino M, Kirino A, Matsumura C, Fukuda K. Urologic abnormalities in Menkes' kinky hair disease: report of three cases. J Pediatr Surg. 1997 May. 32(5):782-4. [Medline].
Cosimo QC, Daniela L, Elsa B, Carlo DV, Giuseppe F. Kinky hair, kinky vessels, and bladder diverticula in Menkes disease. J Neuroimaging. 2011 Apr. 21(2):e114-6. [Medline].
Balestracci A, Caletti MG, Missoni M. A case of Menkes' disease with nephrocalcinosis and chronic renal failure. Pediatr Nephrol. 2009 Jun. 24(6):1255-6. [Medline].
Spitz JL. Genodermatoses. Baltimore, Md: Williams & Wilkins; 1996. Vol 1: 230-1.
Harris ED, Qian Y, Reddy MC. Genes regulating copper metabolism. Mol Cell Biochem. 1998 Nov. 188(1-2):57-62. [Medline].
Liu PC, Chen YW, Centeno JA, Quezado M, Lem K, Kaler SG. Downregulation of myelination, energy, and translational genes in Menkes disease brain. Mol Genet Metab. 2005 Aug. 85(4):291-300. [Medline].
La Fontaine S, Mercer JF. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys. 2007 Jul 15. 463(2):149-67. [Medline].
Madsen E, Gitlin JD. Copper and iron disorders of the brain. Annu Rev Neurosci. 2007. 30:317-37. [Medline].
Madsen E, Gitlin JD. Copper deficiency. Curr Opin Gastroenterol. 2007 Mar. 23(2):187-92. [Medline].
Kim YH, Lee R, Yoo HW, Yum MS, Bae SH, Chung SC, et al. Identification of a novel mutation in the ATP7A gene in a Korean patient with Menkes disease. J Korean Med Sci. 2011 Jul. 26(7):951-3. [Medline]. [Full Text].
Donsante A, Tang J, Godwin SC, et al. Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndrome. J Med Genet. 2007 Aug. 44(8):492-7. [Medline].
Bertini I, Rosato A. Menkes disease. Cell Mol Life Sci. 2008 Jan. 65(1):89-91. [Medline].
Matsuo M, Tasaki R, Kodama H, Hamasaki Y. Screening for Menkes disease using the urine HVA/VMA ratio. J Inherit Metab Dis. 2005. 28(1):89-93. [Medline].
Ozawa H, Kodama H, Kawaguchi H, Mochizuki T, Kobayashi M, Igarashi T. Renal function in patients with Menkes disease. Eur J Pediatr. 2003 Jan. 162(1):51-2. [Medline].
Sheela SR, Latha M, Liu P, Lem K, Kaler SG. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations. Clin Genet. 2005 Sep. 68(3):278-83. [Medline].
Hoppe-Tichy T, Nguyen TH, Hentze BW, Lorke M. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome]. Pharmazie. 2005 Mar. 60(3):205-7. [Medline].
Munakata M, Sakamoto O, Kitamura T, et al. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study. Brain Dev. 2005 Jun. 27(4):297-300. [Medline].
Kaler SG, Holmes CS, Goldstein DS, et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008 Feb 7. 358(6):605-14. [Medline].
Kazim R, Weisberg R, Sun LS. Upper airway obstruction and Menkes syndrome. Anesth Analg. 1993 Oct. 77(4):856-7. [Medline].
Tobias JD. Anaesthetic considerations in the child with Menkes' syndrome. Can J Anaesth. 1992 Sep. 39(7):712-5. [Medline].
Sugimoto M, Shindo K, Shingu K, Mori K. [Anesthetic management of an infant with Menkes disease]. Masui. 1993 Sep. 42(9):1351-4. [Medline].
Watanabe A, Shimizu N. Identification of three novel mutations in Japanese patients with Menkes disease and mutation screening by denaturing high performance liquid chromatography. Pediatr Int. 2005 Feb. 47(1):1-6. [Medline].
Freedberg IM, Eisen AZ, Wolff K. Fitzpatrick's Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999. 732, 2141.
Hurwitz S. Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence. 2nd ed. Philadelphia, Pa: WB Saunders; 1993. 498-9.
Sybert VP. Genetic Skin Disorders. 1st ed. New York, NY: Oxford University Press; 1997. 195-8.